Preventive Vaccine Market is anticipated to reach US$ 55 Bn by 2020 Preventive Vaccine Market 2015-2020: Opportunities | Page 2

Global Preventive Vaccine Market According to the report “Global Preventive Vaccine Market ", published by Market Data Forecast, the global market is projected to reach USD 55 Billion by 2020, at a CAGR of 12.74% from 2015 to 2020. For full report refer to http://www.marketdataforecast.com/market-reports/global-preventivevaccine-market-160/ Globally, the vaccine market has a share of only five percent of the pharmaceuticals market. Nevertheless, it has been showcasing a substantial growth due to the rising incidences of cancer & HIV cases. From USD 5 billion in 2000 to almost USD 25 billion in 2013, it came a long way in the recent years. With the arrival of new therapeutic, preventive and adult vaccines, WHO figures estimate it to rise two-fold over the next five years. It shows how the vaccine market compared to the pharmaceutical market, is relatively small but growing at a fast rate. Despite that it has very diverse features which increase the intricacy of evaluating and understanding the pricing and procurement in their context. Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-preventive-vaccine-market-160/request-sample Rising incidences of infectious diseases, technological advancements that significantly decrease the new vaccine development time, increase in government funding and initiatives by NGO’s are some of the factors that are propelling the vaccines market growth. However, huge investment costs and strict governing policies, high cost associated with treatment are few factors inhibiting the growth of the global preventive vaccines market. 1) By Vaccine Type  Live, Attenuated Vaccines  Inactivated Vaccines  Toxoid Vaccines  Subunit vaccines  Conjugate vaccines  DNA vaccines  Recombinant vector vaccines 2) By End User  Paediatric Vaccine (Pneumococcal, MMR, Varicella, Hepatitis, Poliovirus, HIB and Others)  Adult Vaccines (Influenza, Cervical Cancer, Hepatitis, Zoster and Others) 3) By Geography  North America  Europe  Asia-Pacific  Latin America  Middle-East & Africa Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few [phone] | www.marketdataforecast.com | [email protected]